Applications of inorganic nanoparticles as therapeutic agents.
about
Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart DiseaseAdvanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug DeliveryPhysicochemical properties of nanomaterials: implication in associated toxic manifestationsUptake and metabolism of iron oxide nanoparticles in brain cells.siRNA Delivery Strategies: A Comprehensive Review of Recent Developments.Palladium: a future key player in the nanomedical field?Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.Extracellular polymeric substances (EPS) of freshwater biofilms stabilize and modify CeO2 and Ag nanoparticles.Composites of Polymer Hydrogels and Nanoparticulate Systems for Biomedical and Pharmaceutical Applications.Advances in the synthesis and application of nanoparticles for drug delivery.Difficulties in establishing regulations for engineered nanomaterials and considerations for policy makers: avoiding an unbalance between benefits and risks.Nanotechnology for protein delivery: Overview and perspectives.Assembling Mn:ZnSe quantum dots-siRNA nanoplexes for gene silencing in tumor cells.Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.Genotoxic effects of chromium oxide nanoparticles and microparticles in Wistar rats after 28 days of repeated oral exposure.Self-assemble nanoparticles based on polypeptides containing C-terminal luminescent Pt-cysteine complex.Effect of surfactants on the removal and acute toxicity of aqueous nC60 aggregates in water treatment process.Acetate-Induced Disassembly of Spherical Iron Oxide Nanoparticle Clusters into Monodispersed Core-Shell Structures upon Nanoemulsion Fusion.Multimodal tumor-homing chitosan oligosaccharide-coated biocompatible palladium nanoparticles for photo-based imaging and therapy.Exploring nanoparticle porosity using nano-impacts: platinum nanoparticle aggregates.Understanding nanoparticle porosity via nanoimpacts and XPS: electro-oxidation of platinum nanoparticle aggregates.Platinum nanoparticles inhibit bacteria proliferation and rescue zebrafish from bacterial infectionNanoparticles in biomedical applicationsThe therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction
P2860
Q26770129-91783886-E438-486C-A904-03BCE5A7E090Q28076132-1B1205FE-D320-49AD-B7E1-C633CFC019EBQ28392831-1BDCAA8E-A122-408A-B8D2-F44880CDECB7Q30835947-4B22D735-4585-4927-9F27-CB9E500804B9Q33611947-FE207893-413E-4640-9EA7-C078930F23ABQ33837025-810330C2-3A30-4F16-B5D0-862C86052E4FQ34622662-3F8903D0-9192-4571-B357-8353C156E5C1Q35354182-462719D8-8510-4583-B451-021DCB6B50B0Q37638561-DE22978C-BD30-4BDD-A549-0CD9C12764FAQ38316388-C57E7A08-CC12-4C0B-AD24-D08502551885Q38517151-826CFF35-4462-4691-AA16-43451EB7D98AQ38605185-EB54CD7C-A605-441B-AF11-51A0D8A49B8DQ38848955-BCC8A10D-4EA8-43C2-B4B8-485194CDBD63Q39139112-1BA13957-37FD-46FC-A73F-A0E232C82431Q40391312-DFCA8E69-D27D-47CB-84C0-BFAF11B51C6EQ42324267-8B367344-6D41-4B59-A3D7-565E86195E02Q43328821-69B6B9D8-7711-4C4B-9F6C-0E3F1DF49B98Q47105881-A146FF12-4B8C-4A1B-A281-78709751C6BAQ47721526-1FA71BDE-7B0F-4EC0-B6F0-62A750CD78B9Q48160489-169AC287-AE8A-4A42-85E4-B2F45FEEE9D4Q53111175-3DA9F820-766A-41F4-99CA-0EA8F3C3C020Q58022801-A8411905-F049-4B59-8AC3-2C97D4261376Q58142401-B7949345-9A29-498B-A55B-414E87F941C7Q58698613-BC3AB404-690B-4F72-9984-0081C8E780FD
P2860
Applications of inorganic nanoparticles as therapeutic agents.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Applications of inorganic nanoparticles as therapeutic agents.
@en
type
label
Applications of inorganic nanoparticles as therapeutic agents.
@en
prefLabel
Applications of inorganic nanoparticles as therapeutic agents.
@en
P356
P1433
P1476
Applications of inorganic nanoparticles as therapeutic agents
@en
P2093
Taeghwan Hyeon
P304
P356
10.1088/0957-4484/25/1/012001
P50
P577
2013-12-11T00:00:00Z